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AbstrACt
Objective Systematic reviews often rely on the acquisition 
of unpublished analyses or data. We carried out a nested 
randomised trial comparing two different approaches 
for contacting authors to request additional data for a 
systematic review.
Participants Participants were authors of published 
reports of prevention or treatment trials in stroke in 
which there was central adjudication of events. A primary 
and secondary research active author were selected as 
contacts for each trial.
Interventions Authors were randomised to be sent either 
a short email with a protocol of the systematic review 
attached (‘Short’) or a longer email that contained detailed 
information and without the protocol attached (‘Long’). A 
maximum of two emails were sent to each author to obtain 
a response. The unit of analysis was trial, accounting for 
clustering by author.
Primary and secondary outcome measures The 
primary outcome was whether a response was received 
from authors. Secondary outcomes included time to 
response, number of reminders needed before a response 
was received and whether authors agreed to collaborate.
results 88 trials with 76 primary authors were identified 
in the systematic review, and of these, 36 authors were 
randomised to Short (trials=45) and 40 to Long (trials=43). 
Responses were received for 69 trials. There was no 
evidence of a difference in response rate between trial 
arms (Short vs Long, OR 1.10, 95% CI 0.36 to 3.33). 
There was no evidence of a difference in time to response 
between trial arms (Short vs Long, HR 0.91, 95% CI 0.55 to 
1.51). In total, 27% of authors responded within a day and 
22% of authors never responded.
Conclusions There was no evidence to suggest that 
email format had an impact on the number of responses 
received when acquiring data for a systematic review 
involving stroke trials or the time taken to receive these 
responses.
IntrOduCtIOn  
Systematic reviews are often considered as the 
highest level of evidence available.1 However, 
meta-analyses, the statistical component of a 
systematic review, often rely on the acquisition 
of unpublished summary results or further 
data. It can be a challenge to obtain this data, 
especially if the meta-analysis requires indi-
vidual patient data,2 3 resulting in insufficient 
studies to pool together.4 
Data sharing is not yet common practice in 
the field of biomedical research, and many 
researchers struggle to acquire the underlying 
data sets used in journal articles.5 There are 
many reasons why there may be difficulties in 
acquiring data; authors may not wish to share 
their data,6 they may be too busy to respond or 
deal with requests,4 they may have moved insti-
tution and be uncontactable, the data could 
have been lost or destroyed, or authors may not 
have access to the data.7 Author inclination to 
share data could be related to the strength of 
evidence and the perceived quality of statistical 
results from their study.8 Research studies that 
report borderline evidence of an intervention 
effect may be less likely to take part in data 
strengths and limitations of this study
 ► This is the first randomised trial comparing different 
email formats when contacting authors to request 
unpublished data for a systematic review.
 ► This study follows a clear and rigorous protocol, 
guided by experienced methodologists, and imple-
mented in a clinical trials unit.
 ► Blinding was not possible as it was clear which 
format of email had been sent. However, contacted 
authors were not aware of this trial during the study, 
and therefore, we expected that their response rate 
and time to response would remain unbiased.
 ► The sample size is constrained by the number of el-
igible studies identified for the systematic review. It 
is possible that a larger study would detect small but 
important effects of email format and presence or 
absence of an attachment on response rate. 
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sharing, which would result in publication bias for a system-
atic review.9 Various methods are currently employed to 
encourage authors to share data for a systematic review, and 
a randomised trial investigating if financial incentives may 
be effective is currently under way.10 Additionally, academic 
incentives for making data available could be introduced, 
such as invitation into group collaboration, or having data 
sharing recognised to an equivalent level as scientific presen-
tations or journal publications.11
There appears to be no consensus about the best way 
to approach authors to contact them for data. The corre-
sponding author should be the most appropriate person 
to contact when attempting to acquire unpublished clin-
ical trial data, but contacting these authors may be chal-
lenging as they could be inaccessible or have little time to 
deal with requests.12 Therefore, if email contact is used, 
this must be clear, concise and easy to respond to. Some 
authors may prefer a shorter email, with additional infor-
mation attached, while others may prefer a longer email 
with sufficient information they need to make a decision 
without reading additional attached information such as 
a study protocol.
The initial interaction with any author may have a large 
impact on whether they collaborate, or even on whether 
they reply at all. The first step when attempting to acquire 
data is to open up a channel of communication with the 
data custodian, assumed in this paper to be the author of 
the journal article. Thus, an important outcome to assess 
is whether an initial response is received, before consid-
ering if interaction with the author affects willingness to 
share data.
We carried out a nested randomised trial, which investi-
gated two different approaches to contacting authors for 
data in a systematic review, with the primary aim of seeing 
which method elicits the most complete response.
MethOds
Participants
The systematic review chosen for this study investigates 
whether central adjudication of the primary outcome 
in stroke trials has any impact on the main trial primary 
analysis.13 Since the information required for the review 
is not commonly published in the main or secondary trial 
publications, author contact is essential which makes 
it a useful setting to test the effect of different ways of 
contacting authors on response rate.
In brief, the studies included were those adjudged to 
be randomised trials of prevention or treatment of stroke, 
which had centrally adjudicated their primary outcome. 
MEDLINE, Embase, the Cochrane Central Register of 
Controlled Trials, Web of Science, PsycINFO and Google 
Scholar were searched for relevant articles. We restricted 
searches from Google Scholar to the first 300 articles,14 
and only articles written in English were considered.
Two author contacts were chosen from each identified 
trial, and these were the participants selected for this study. 
The primary contact was ideally one of the corresponding 
authors. This author was checked on PubMed to iden-
tify whether they were still an active researcher (paper 
published within the last two years). If the corresponding 
author appeared to have ceased research activity, then a 
secondary author who was still an active researcher (pref-
erably first/second/last) was selected as the primary point 
of contact. Additionally, a second research active author 
was chosen as a second contact for the trial. Ideally, this 
second contact also had a major role in the trial, deter-
mined by their position on the main trial publication and 
in the author contribution section of the manuscript, if 
completed.
Authors were invited to collaborate in our research 
programme investigating adjudication in stroke trials. 
In order to collaborate, they were asked to provide data 
in one of two formats: individual participant data or 
summary results. Authors that provided data were given 
the opportunity to critically review the findings and draft 
manuscript. Those that accepted this offer were invited to 
join the systematic review writing committee.
Patient and public involvement
Patients were not involved in this study.
trial design
This study was a parallel group, randomised trial of short 
email and attachment versus long email to elicit response 
from potential collaborators. The trial was nested within 
a systematic review and meta-analysis. Blinding was not 
possible, as it was clear to contacted authors and the trial 
team which format of email had been sent. However, 
contacted authors were unaware that alternative formats 
of contact email were being compared in a nested 
randomised study, and therefore, we expected that their 
willingness to respond would be unbiased.
randomisation
Randomisation occurred at author level. This was to 
ensure that if any author had published multiple trials that 
were to be included, then they only received one email, 
rather than multiple emails, which could be in different 
formats. Randomisation was stratified by year of publica-
tion (median split: <2011/≥2011), size of trial (median 
split: <1738/≥1738) and if the author had multiple trials 
which are included (yes/no). Therefore, there were 
eight strata. If authors had multiple trials, then the with-
in-author median size and median year were used when 
stratifying. Allocation was concealed and a researcher 
not involved in the trial randomised participants using a 
computer-generated random number list.
Participants were randomised in a 1:1 ratio to either of 
the two treatment groups: (1) Short, where they received 
a short email message that fits on one screen without the 
need to scroll, with the protocol attached (Intervention 
group); (2) Long, where they received a longer email 
message that contained a fuller description of the system-
atic review and request for information, with the protocol 
available on request (Comparator group). The protocol 
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detailed the purpose of the systematic review, the data that 
was requested and the planned programme of research 
(see online supplementary appendices A and B).
Plan for eliciting response
Each author received a maximum of two emails. The 
primary contact was first sent an email in the format of 
the randomly allocated intervention. If no response was 
received, then a second email was sent 28 days later, which 
included some additional brief reminder text, which was 
the same for both groups, added at the top of the original 
email (achieved using Reply to all in Outlook).
If there was still no response from the primary contact 
author after a further 21 days, the second contact author was 
sent an email in an identical format, waiting 28 days before 
a reminder was sent. The second contact was not emailed if 
the first contact responded within the 7-week time frame. 
Therefore, there was a maximum of four emails in total that 
authors received if there was no response. Participants were 
followed up for a further 11 weeks after the fourth and final 
email. After this stage, any authors that had not responded 
were recorded as non-respondents, regardless of contact 
thereafter (figure 1).
Outcome measures
The primary outcome for this nested randomised trial 
was whether a response was received from either of the 
two contacted authors in the trial time frame. This was a 
binary outcome (response received, yes/no). Out-of-of-
fice automatic replies were not counted as a response, 
and no additional emails were sent on receipt of an 
out-of-office reply.
Secondary outcomes were time to response, measured 
in days and the number of emails needed to respond. On 
receipt of an initial response, this was categorised as either 
being negative, neutral or positive. Positive responses were 
allocated if there was an interest in the collaboration and 
research questions, above simply asking for further infor-
mation. Negative responses were assigned if participants 
gave the indication that they did not want to be involved/
did not have time to take part. All other responses were 
coded as neutral.
The eventual outcome on the end of the trial time frame 
was allocated as either (1) agree to collaborate, (2) do 
not agree to collaborate, (3) no decision reached or 
(4) no response. If there was an agreement in principle 
regardless of whether data had been received, then this 
was assigned as agree. If there was a clear indication that 
the author could not/did not want to help, then this was 
allocated do not agree. No decision reached was given if 
it was still unclear whether the author would be willing to 
take part in the collaboration.
statistical analysis
The sample size for this nested randomised trial was 
fixed by the number of studies identified in the system-
atic review, and although allocation was by author, the 
unit of analysis is the individual trial. A sample size of 88 
trials could detect a difference in response rate between 
groups of ≤30 percentage points (equivalent OR 3.4) with 
80% power and 5% two-sided alpha, ignoring any reduc-
tion in effective sample size due to the clustering effect 
of authors with multiple studies. The characteristics of 
each trial were summarised using appropriate descrip-
tive statistics for each intervention arm. The primary 
approach to between-group comparative analyses was by 
intention-to-treat. Short was treated as the intervention 
group and Long treated as the comparator group for all 
between-group analyses. The evaluation of response rate 
was performed using adjusted logistic regression models. 
The adjusted model included stratification factors; year 
of trial publication, trial sample size and multiple trials 
per author. The primary efficacy parameter comparing 
interventions was the OR along with the corresponding 
95% CI. Robust SEs were used to account for correlation 
between multiple trials for the same author. A sensitivity 
analysis was carried out by further adjusting the primary 
analysis model for any characteristics of trials with marked 
imbalance between intervention groups.
Time to response was investigated using survival anal-
ysis, with response being the outcome of interest. Adjusted 
HRs, adjusted for stratification factors, were reported 
alongside 95% CIs. Additional secondary outcomes were 
summarised using mean, SD, median, lower and upper 
quartiles, or frequency counts and percentages where 
appropriate. All analyses were performed in Stata V.15.0 
or later.
results
The study commenced on 11 July 2017. Eighty-eight trials 
were identified from a systematic search of the litera-
ture and were to be included in the review. This corre-
sponded to 76 unique authors who were selected as the 
primary contact for these studies. In total, 36 authors 
were randomised to Short (45 trials) and 40 to Long (43 
trials) email formats. The majority of the studies had their 
main publication published between 2006 and 2015, were 
either primary or secondary prevention stroke trials, were 
carried out in >50 trial centres and had a median number 
of patients randomised >1000 (table 1). Trials randomised 
to each group had similar study design, intervention type 
and comparator, but studies allocated to Long tended to 
have more participants included and a larger number 
of trial centres. The number of intervention groups was 
similar for studies allocated to either Short or Long.
Figure 1 Plan to elicit response.
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The majority of authors chosen as the primary contact 
were the first author of the main publication or listed 
first in the writing committee if the article was published 
under a collaborative group. Conversely, the last author 
was the most common choice for the second contact, 
although there was greater variation in choice for this 
contact, with a position other than first, second or last 
also prevalent. For studies allocated to Long, the primary 
contact was more likely to be the corresponding author 
compared with trials allocated to Short, although author 
position was similar for both groups (table 1).
In all, responses were received for 69 trials, with authors 
of 19 studies (22%) never responding. There was no 
evidence of a difference in response rate between trial 
arms (table 2 and online supplementary appendix C). 
Average time to response was marginally quicker among 
those allocated to Short, with a greater proportion of 
authors in this trial arm responding to the first email, 
but there was insufficient evidence to determine a differ-
ence between trial arms on time to response (table 3 and 
figure 2). In total, 27% of authors responded within a day 
and 38% replied within a week.
Table 2 Primary outcome: response from contacted 
authors
Response Adjusted OR (95% CI) P value
Short message 
and protocol
36/45 (80%) 1.10 (0.36 to 3.33) 0.87
Long message 33/43 (77%)
Adjusted for year of publication, size of trial and if the author had 
multiple trials included. Total N included=88. Robust SEs were 
used in model fitting.
Table 1 Characteristics of included trials
Short message and 
protocol (n=45) Long message (n=43)




  1 30 (83%) 37 (93%)
  2 4 (11%) 3 (8%)
  3 1 (3%) 0 (0%)
  4 1 (3%) 0 (0%)
Year of main trial 
publication
  1990–2000 5 (11%) 2 (5%)
  2001–2005 7 (16%) 3 (7%)
  2006–2010 11 (24%) 11 (26%)
  2011–2015 19 (42%) 22 (51%)
  2016–2017 3 (7%) 5 (12%)
Patients randomised
  Mean [SD] 3910.8 [5593.4] 3755.7 [5154.8]
  Median [25th, 75th 
centile]
1224 [439, 5170] 1809 [500, 4576]
  Min, max 74, 20 332 48, 21 105
Type of trial
  Primary prevention 20 (44%) 16 (37%)
  Secondary prevention 19 (42%) 21 (49%)
  Acute stroke 6 (13%) 6 (14%)
Setting
  1 continent 30 (67%) 17 (40%)
  >1 continent 14 (31%) 23 (53%)
  Not found 1 (2%) 3 (7%)
Number of centres
  Mean [SD] 212.8 [286.7] 165.5 [293.4]
  Median [25th, 75th 
centile]
67 [27, 260] 85 [32, 141]
  Min, max 1, 1034 4, 1393
Study design
  Parallel† 44 (98%) 41 (95%)
  Factorial 1 (2%) 2 (5%)
Intervention
  Drug 30 (67%) 31 (72%)
  Surgery/procedure 12 (27%) 11 (26%)
  Device 2 (4%) 1 (2%)
  Diet 1 (2%) 0 (0%)
Comparator
  Placebo 6 (13%) 10 (23%)
  Standard care 28 (62%) 24 (56%)
  Active treatment 8 (18%) 6 (14%)
  Surgery/procedure 3 (7%) 3 (7%)
Number of intervention 
groups
  2 39 (87%) 38 (88%)
  3 4 (9%) 3 (7%)
Continued
Short message and 
protocol (n=45) Long message (n=43)
  4 1 (2%) 1 (2%)
  >4 1 (2%) 1 (2%)
Primary contact
  First author 32 (71%) 30 (70%)
  Second author 2 (4%) 3 (7%)
  Last author 4 (9%) 5 (12%)
  Other 7 (16%) 5 (12%)
Corresponding author 32 (71%) 37 (86%)
Secondary contact
  First author 5 (11%) 7 (16%)
  Second author 8 (18%) 9 (21%)
  Last author 18 (40%) 17 (40%)
  Other 14 (31%) 10 (23%)
Corresponding author 4 (9%) 3 (7%)
Data are n (%) unless otherwise specified.
*Unit of allocation was carried out at author level; therefore, number of 
trials per author do not sum to total N.
†Two parallel trials were cluster randomised (Short=1; Long=1).
Table 1 Continued 
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A short email elicited a more favourable first response, 
with few negative replies. However, this did not lead to a 
larger number of authors agreeing to collaborate, with 
many authors not following up on their positive intent. 
Conversely, those allocated the longer email were more 
likely to respond in a negative fashion, but this meant that 
the decision not to collaborate was established sooner, 
and there was a smaller proportion with no decision 
reached (table 4).
dIsCussIOn
This nested randomised trial found no evidence that email 
format or presence or absence of an attachment had an 
impact on author response when attempting to acquire 
data for a systematic review. Authors responded in a similar 
time frame and needed a similar number of reminders 
before a response was received. There was some indication 
that authors that received a shorter email were more likely 
to respond positively at first, but there was no evidence that 
email format changed the likelihood of collaboration.
Approximately three-quarters of authors in the study 
responded regardless of email format. A study which 
attempted to contact authors to obtain data for a diag-
nostic accuracy review for hepatic fibrosis found a similar 
response rate, with 68% of authors responding to requests 
for data.15 For both email formats we included text which 
invited authors who provided data into a collaboration to 
assist (at their discretion) with interpretation and write-up 
of results, and co-authorship as part of a collaborative 
group. Our view was that offering greater opportunity for 
collaboration to authors rather than simply providing 
data or further results might produce a greater and more 
complete response. Offering collaboration may have influ-
enced overall response rate, and thus the results of this study 
may not be generalisable to others where collaboration 
is not offered. For example, a study which aimed to estab-
lish whether corresponding authors accepted responsibility 
of correspondence, where collaboration was not offered, 
found a far lower response rate (190/446, 43%).12 A qual-
itative interview study which investigated strategies to access 
unpublished clinical trial data mentioned a lack of collabo-
ration as a main barrier to data sharing.16 Thus, offering the 
opportunity for authors to collaborate and being upfront 
about giving collaborators the chance to input in both inter-
preting results and the write-up of any papers could give a 
more positive and thorough response.
Table 3 Time to response (days)
Time to response
Adjusted HR (95% CI) P valueMean [SD] Median [25th, 75th centile]
Short message and protocol 51.6 [64.7] 28 [1, 77] 0.91 (0.55 to 1.51) 0.72 
Long message 60 [65.3] 42 [1, 77]
Adjusted for year of publication, size of trial and if the author had multiple trials included. Total N included=88.
Figure 2 Kaplan-Meier curve for time to response for both 
intervention groups.







Number of emails before response received
  1 16 (44%) 15 (38%)
  2 6 (17%) 10 (25%)
  3 3 (8%) 3 (8%)
  4 2 (6%) 2 (5%)
  No response 9 (25%) 10 (25%)
  Mean [SD] 1.7 [1.0] 1.7 [0.9]
  Median [25th, 75th centile] 1 [1, 2] 1.5 [1, 2]
  Min, max 1, 4 1, 4
First response outcome
  Negative 2 (6%) 8 (20%)
  Neutral 9 (25%) 14 (35%)
  Positive 16 (44%) 8 (20%)
Eventual outcome
  Agree to collaborate 11 (31%) 10 (25%)
  Do not agree to 
collaborate
3 (8%) 11 (28%)
  No decision reached 13 (36%) 9 (23%)
  No response 9 (25%) 10 (25%)
Data are n (%) unless otherwise specified. Data are presented on 
author level, rather than trial level.
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While short emails elicited a marginally quicker response 
on average, there was insufficient evidence to conclude 
benefit of this email style on time to response. Selph et al15 
found that responses were received from 23% of authors 
after one request, with 55% responding after just two 
requests (one reminder). This is similar to our study, where 
we found that 41% of authors had responded after one 
email and two emails (one reminder) elicited 62% response 
rate. A third email provided 70% response rate, with little 
further improvement following a fourth email. The number 
of emails sent and the number sent to each contact (if there 
are multiple like in our study) are additional areas where 
similar research could help to introduce a more rigorous 
evidence base.
There was some indication that authors allocated to a short 
email format were more likely to respond positively, with only 
two negative first responses received from these authors, 
and double the number of positive responses. However, the 
number of authors eventually agreeing to collaborate was 
similar for both groups. This suggests that while the long 
email format resulted in more negative initial responses, 
authors who did respond were aware of the implications 
of our study and could make an informed decision. Thus, 
the majority of positive first responses to those allocated to 
the long email format turned into collaboration. It could be 
hypothesised that while those allocated to the short email 
format had a detailed protocol attached, authors may not 
have opened attachments and therefore were agreeing to be 
involved in the study without fully realised the commitment. 
This led to a far larger amount of time and resource dealing 
with these authors, who eventually declined to collaborate, 
or no decision was reached in the trial time frame.
A limitation of this study was the constrained sample 
size, enforced by the systematic within which this study was 
nested. Thus, power to detect a small difference in response 
rate was low. However, this study does provide a framework 
to carry out a larger trial of this kind. A further limitation of 
our trial was that blinding was not possible because the inves-
tigator was responsible for sending all emails and collating 
the data. It was impossible to mask which intervention 
participants were assigned to due to the email thread being 
used to reply to messages and send reminders. Therefore, 
there is a possibility that some outcomes are at a risk of bias. 
Furthermore, the eventual outcome was not expected to be 
greatly influenced by the intervention and was more reliant 
on subsequent communication such as emails or phone 
contact. However, the protocol was finalised in advance of 
randomisation, and the trial team followed this protocol, 
therefore the risk of bias from the trial team was low. In 
addition, study authors, although aware of email format they 
received, were not aware of the alternative email format nor 
were they aware of the nested randomised study, therefore 
the risk of bias from participants was low.
It could be argued that this study did not investigate what 
could be perceived as the key question, whether data were 
shared. This was due to our belief that whether authors 
provided data was dependent on other factors, and not the 
original email length and style. Our study investigated an 
intervention which allows researchers to open up a channel 
of communication with the data custodian, and there is the 
potential to use a different intervention to evaluate how best 
to acquire data (eg, financial incentives10).
This nested randomised trial found no evidence that 
email length had an impact on author response, or agree-
ment to collaborate, when attempting to acquire data in our 
systematic review. Further studies could test similar hypoth-
eses to evaluate this further, with a greater sample size and 
in a different clinical area. Given this issue involves count-
less researchers who strive to generate high-quality research 
through systematic reviews, this problem seems one that is 
not only important to tackle, but could be potentially simple 
to answer. While the first question has to be whether an 
author responds, the more important question to answer is 
whether or not an author agrees to collaborate, and argu-
ably even more important, whether or not data are shared. 
These questions go far beyond the scope of this small trial, 
but future studies building on this could investigate these 
issues and attempt to find an intervention that not only 
boosts response, but also boosts collaboration.
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